Abstract
It is known for a long time that the stratum corneum is the main barrier that prevents transdermal delivery of water-soluble drugs, peptides, and proteins. Attempts to overcome this barrier include the development of transdermal delivery systems that are based on fractional ablation of the stratum corneum and epidermis, thus forming multiple of tiny transient pores in a specific zone of the outer skin layers. The ablation was done by various physical energy methods, based on heat, high-frequency electrical current, or laser energy. Formation of multiple tiny pores in the skin enabled efficient transdermal delivery of therapeutic doses of highly water-soluble drugs, including a variety of peptides and proteins. This chapter discusses the unique properties of these transdermal delivery methods, as well as the potential uses of these techniques, such as delivery of active biological compounds as an alternative to injection, transcutaneous vaccination, or delivery of genes into skin cells.
This is a preview of subscription content, log in via an institution to check access.
References
Alexander A, Dwivedi S, Ajazuddin, Giri TK, Saraf S, Tripathi DK (2012) Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 164(1):26–40
Bach D, Weiss R, Hessenberger M, Kitzmueller S, Weinberger EE, Krautgartner WD, Hauser-Kronberger C, Boehler C, Thalhamer J, Scheiblhfer S (2012) Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5- sensitized mice. Allergy 67:1365–1374
Bachhav YG, Summer S, Heinrich A, Bragagna T, Bohler C andKalia YN (2010) Effect of controlled microporation of drug transport kinetics into and across the skin. J Controlled Rel 146:31–36
Badkar AV, Smith AM, Eppstein JA, Banga AK (2007) Transdermal delivery of interferon Alpha-2b using microporation and iontophoresis in Hairless Rats. Pharm Res 24(7):1389–1395
Birchall J, Coulmana S, Anstey A, Gateley C, Sweetland H, Gershonowitz A, Neville L, Levin G (2006) Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm 312:15–23
Eppstein J, Enscore D, Tagliaferri F, Tolia G, Chang S, Smith A, Patel Y, McRae S (2007) Permeant delivery system and methods for use thereof. US Patent application 2007/0031495 A1
Kam Y, Sacks H, Mevorat-Kaplan K, Stern M, Levin G (2012) Radio frequency-microchannels for transdermal delivery: characterization of skin recovery and delivery window. Pharmacol Pharm 3:20–28
Kim J, Jang JH, Lee JH, Choi JK, Park WR, Bae IH, Bae J, Park JW (2012) Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation. Pharm Res 29:2017–2029
Lane ME (2013) Skin penetration enhancers. Int J Pharm 447(1–2):12–21
Lee JW, Gadiraja P, Park JH, Allen MG, Prausnitz MR (2011) Microsecond thermal ablation of skin for transdermal drug delivery. J Control Release 154(1):58–68
Levin G (2008) Advances in radio-frequency transdermal drug delivery. Pharm Tech Drug Delivery 32:S12–S19
Levin G, Daniel D (2008) Transdermal delivery system for anti-emetic medication. US patent 7,415, 306 B2
Levin G, Gershonowitz A, Sacks H, Stern M, Sherman A, Rudaev S, Zivin I, Phillip M (2005) Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 22(4):550–555
Levin G, Gershonowitz A, Gadasi H (2006) Delivery system for transdermal immunization. WO 2006/003659
Nakano M, Uenaka K, Tsujimoto M, Loghin C, Hu L, Stock J, Kochba E, Kenan Y (2011) Safety, tolerability, pharmacokinetics, and pharmacodynamics of Teriparatide administered transdermally in Japanese postmenopausal women. American Society for Bone and Mineral Research (ASBMR) annual meeting, San Diego, 16–20 Sept 2011
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268
Sintov AC, Krymberk I, Daniel D, Hannan T, Sohn Z, Levin G (2003) Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release 89:311–320
Smith A, Tomlinson E (2008) The PassPort™ system: a new transdermal patch for water-soluble drugs, proteins, and carbohydrates. In: Rathbone MJ, Hadgraft J, Roberts MS, Lane ME (eds.), Modified-release drug delivery technology, 2nd edn, Vol 2, Chapter 31, CRC Press
Stern M, Levin G (2008) Transdermal delivery system for dried particulate or lyophilized medications. US patent No. 7,335,377
Stern M, Levin G (2012) Transdermal delivery system for dried particulate or lyophilized medications. US patent No 8,133,505 B2
Weiss R, Hessenberger M, Kizmuller S, Bach D, Weinberger EE, Krautgartner WD, Hauser-Kronberger C, Malissen B, Boehler C, Kalia YN, Thalhamer J, Scheiblhofer S (2012) Transcutaneous vaccination via laser microporation. J Control Release 162(2):391–399
Yu J, Bachhav YG, Summer S, Heinrich A, Bragagna T, Bohler C, Kalia YN (2010) Using controlled laser-microporation to increase transdermal delivery of prednisone. J Control Release 148:e71–e73
Zech NH, Murtinger M, Uher P (2011) Pregnancy after ovarian superovulation by transdermal delivery of follicle-stimulating hormone. Fertil Steril 95:2784–2785
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Levin, G. (2017). Skin Ablation Methods for Transdermal Drug Delivery. In: Dragicevic, N., I. Maibach, H. (eds) Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53273-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-53273-7_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53271-3
Online ISBN: 978-3-662-53273-7
eBook Packages: MedicineMedicine (R0)